Search - tctmd.com

Displaying 1 - 20 of 102

Sort: Relevancy | Date

News Conference News ACC 2026

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

Todd Neale

April 01, 2026

News Conference News ACC 2026

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

Todd Neale

March 30, 2026

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Caitlin E. Cox

March 30, 2026

Presentation ACC 2026

Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Adam Greenbaum

March 29, 2026

Presentation ACC 2026

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Presenter: Dimytri Siqueira

March 29, 2026

Presentation ACC 2026

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation

Presenter: Erwan Donal

March 29, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

L.A. McKeown

March 30, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

Presentation ACC 2025

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Presenter: Saibal Kar

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News ACC 2024

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Yael L. Maxwell

April 05, 2024

News Conference News ACC 2023

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

Shelley Wood

March 10, 2023

News Conference News ACC 2023

COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows

Shelley Wood

March 05, 2023

Presentation ACC 2023

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

Presenter: John K. Forrest

March 05, 2023

Presentation ACC 2023

A Landmark Randomized Clinical Trial of Transcatheter Repair for Tricuspid Regurgitation

Presenter: Paul Sorajja

March 05, 2023

Presentation ACC 2023

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Presenter: Gregg W. Stone

March 05, 2023

Advertisement

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial

Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation

What’s Going to Be Hot at ACC 2026

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial

Dapagliflozin after Transcatheter Aortic Valve Implantation

What’s Going to Be Hot at ACC 2025?

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England

Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better

COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows

Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial

A Landmark Randomized Clinical Trial of Transcatheter Repair for Tricuspid Regurgitation

5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content